MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association
The MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association ranks among the top institutions in the world for basic biomedical research. MDC scientists use state-of-the-art methods of molecular biology and genetic engineering in order to understand the development of complex diseases at their origin, in the genes. On this basis, they seek to develop new methods to diagnose, treat and prevent diseases. Research activities at the MDC are divided into four main areas: cardiovascular and metabolic diseases, cancer, diseases of the nervous system and medical systems biology. MDC researchers collaborate closely with the Charité in the Experimental and Clinical Research Center and also with biotech companies located on Campus Berlin-Buch. The MDC currently employs approximately 1,700 staff members, including guest scientists, and has state-of-the-art technology platforms such as 7 Tesla ultra high field MRI, electron microscopy or bioinformatics.
Leibniz Research Institute for Molecular Pharmacology (FMP)
How do diseases develop? Which drugs can specifically target and intervene in the biochemistry of the body? Research activities at the Leibniz Research Institute for Molecular Pharmacology (FMP), Germany’s only non-university research institute for pharmacology, are concerned with these questions. Chemists, biologists, pharmacologists, physicists and physicians collaborate closely to lay the basis for the development of future drugs.
The FMP cooperates with other Berlin research institutions such as the Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin and is part of several research projects, such as the Neurocure cluster of excellence. The institute is also one of the initiators of the large-scale European project EU-OPENSCREEN, in which institutions from various European countries want to coordinate the search for new drugs, and part of the new European network “Instruct”, which seeks to link the highly sophisticated technologies in structural biology.
The institute has a staff of 300 employees and is a member of the Leibniz Association and the Forschungsverbund Berlin e.V. (Berlin Research Association).
News research
From cell biology to CRISPR/Cas – new knowledge for schools
The Life Science Learning Lab at the Berlin-Buch research campus offers both school students and teachers the opportunity to immerse themselves in science. This year, the facility celebrates its 25th ...
more ...ERC grants Berlin scientists € 2.5 million each
Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that u...
more ...The Protein Expert
Prof. Dr. Fan Liu from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has recently received several awards for her contributions to the field of cross-linking mass spectrometry.
more ...Events Campus
16.05.2024, 17:00
Talk im Cube: "Sustainable Practices in Life Sciences - A Panel Discussion" (in English)
This panel will delve into the evolving landscape of sustainability in life sciences, exploring strategies for academic institutions, start-ups, biotech and pharmaceutical companies to navigate regula...
more ...22.05.2024, 16:00
Labor trifft Lehrer*in: "Proteinfahndung mit Massenspektrometern"
Fortbildung für Lehrer:innen am Max Delbrück Center, AG Prof. Selbach
more ...22.06.2024, 16:00
Herzlich willkommen zur Langen Nacht der Wissenschaften am 22. Juni in Buch!
Forschung erleben, wenn die Einrichtungen des Campus Berlin-Buch zur Langen Nacht der Wissenschaften am 22. Juni 2024 ihre Türen öffnen. Es erwartet Sie ein Programm für die ganze Familie mit Mitmacha...
more ...